Altered Habenula Activity following Ketamine Administration in Treatment-Resistant Major Depression

被引:0
|
作者
Carlson, Paul J. [1 ,2 ]
DiazGranados, Nancy [3 ]
Nugent, Allison [4 ]
Ibrahim, Lobna [4 ]
Luckenbaugh, David [4 ]
Tinsley, Ruth [4 ]
Brutsche, Nancy [4 ]
Herscovitch, Peter [5 ]
Manji, Husseini K. [6 ,7 ]
Zarate, Carlos A. [4 ]
Drevets, Wayne C. [8 ]
机构
[1] Salt Lake VAMC, Salt Lake City, UT USA
[2] Univ Utah, Sch Med, Salt Lake City, UT USA
[3] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[4] NIMH, Expt Therapeut & Pathophysiol Branch, DIRP, NIH, Bethesda, MD 20892 USA
[5] NIH, Positron Emiss Tomog Dept, Ctr Clin, Bethesda, MD 20892 USA
[6] CNS, Titusville, NJ USA
[7] Pain Johnson & Johnson, Titusville, NJ USA
[8] Univ Oklahoma, Laureate Inst Brain Res, Coll Med, Tulsa, OK USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
537
引用
收藏
页码:160S / 161S
页数:2
相关论文
共 50 条
  • [1] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
    Rivas-Grajales, Ana Maria
    Salas, Ramiro
    Robinson, Meghan E.
    Qi, Karen
    Murrough, James W.
    Mathew, Sanjay J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 383 - 391
  • [2] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    [J]. PHARMACEUTICALS, 2021, 14 (05)
  • [3] Noninferior to ketamine for treatment-resistant major depression without psychosis
    Lampl, Benedikt M. J.
    [J]. ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2024, 59 (05):
  • [4] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 128S - 128S
  • [5] Intravenous ketamine therapy in a patient with a treatment-resistant major depression
    Liebrenz, Michael
    Borgeat, Alain
    Leisinger, Ria
    Stohler, Rudolf
    [J]. SWISS MEDICAL WEEKLY, 2007, 137 (15-16) : 234 - 236
  • [6] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Anand, A.
    Mathew, S. J.
    Sanacora, G.
    Murrough, J. W.
    Goes, F. S.
    Altinay, M.
    Aloysi, A. S.
    Asghar-Ali, A. A.
    Barnett, B. S.
    Chang, L. C.
    Collins, K. A.
    Costi, S.
    Iqbal, S.
    Jha, M. K.
    Krishnan, K.
    Malone, D. A.
    Nikayin, S.
    Nissen, S. E.
    Ostroff, R. B.
    Reti, I. M.
    Wilkinson, S. T.
    Wolski, K.
    Hu, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (25): : 2315 - 2325
  • [7] Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
    Niciu, Mark J.
    Luckenbaugh, David A.
    Ionescu, Dawn F.
    Guevara, Sara
    Machado-Vieira, Rodrigo
    Richards, Erica M.
    Brutsche, Nancy E.
    Nolan, Neal M.
    Zarate, Carlos A., Jr.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (05) : E417 - E423
  • [8] Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Souza, Sergio A.
    Josino, Taina R.
    Bisol, Luisa W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (10): : 959 - 962
  • [9] The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
    Hashimoto, Kenji
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2014, 12 (01) : 72 - 73
  • [10] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
    Holsinger, Tracey
    Riordan, Paul
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105